Atorvastatin Calcium Inhibits PDGF-ββ-Induced Proliferation and Migration of VSMCs Through the G0/G1 Cell Cycle Arrest and Suppression of Activated PDGFRβ-PI3K-Akt Signaling Cascade

Autor: Xiaofan Guo, Naijin Zhang, Yingxian Sun, Zhao Li, Siyuan Dong, Shuang Chen, Bo Yu
Rok vydání: 2017
Předmět:
0301 basic medicine
MAPK/ERK pathway
Male
Cell cycle checkpoint
Cyclin E
Physiology
PDGF-ββ
Becaplermin
lcsh:Physiology
Muscle
Smooth
Vascular

lcsh:Biochemistry
Rats
Sprague-Dawley

Receptor
Platelet-Derived Growth Factor beta

03 medical and health sciences
Phosphatidylinositol 3-Kinases
0302 clinical medicine
Cell Movement
Proliferating Cell Nuclear Antigen
Vascular smooth muscle cells
Atorvastatin
Animals
lcsh:QD415-436
Cyclin D1
Phosphorylation
Protein kinase B
Cells
Cultured

Cell Proliferation
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
biology
lcsh:QP1-981
Cell growth
Chemistry
Phospholipase C gamma
Akt
Cell migration
Proto-Oncogene Proteins c-sis
G1 Phase Cell Cycle Checkpoints
Cell biology
Rats
030104 developmental biology
030220 oncology & carcinogenesis
Atorvastatin calcium
biology.protein
G1 phase
Proto-Oncogene Proteins c-akt
Platelet-derived growth factor receptor
Signal Transduction
Zdroj: Cellular Physiology and Biochemistry, Vol 44, Iss 1, Pp 215-228 (2017)
ISSN: 1421-9778
Popis: Background/Aims: Abnormal proliferation of vascular smooth muscle cells (VSMCs) is a hallmark of vascular lesions, such as atherosclerosis and restenosis. PDGF-ββ, an isoform of PDGF (platelet-derived growth factor), has been demonstrated to induce proliferation and migration of VSMCs. Atorvastatin calcium, a selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, has favorable protective effects on VSMCs. This study examined the effects of atorvastatin calcium on the proliferation and migration of PDGF-ββ-treated VSMCs, as well as its underlying mechanisms. Methods: MTT assays, Edu imaging, cell cycle analysis, wound healing assays, transwell migration assays, and western blot analysis were performed. Results: Atorvastatin calcium significantly inhibited cell proliferation, DNA synthesis and cell migration of PDGF-ββ-treated VSMCs. We demonstrated that atorvastatin calcium induced cell cycle arrest in the G0/G1 phase in response to PDGF-ββ stimulation and decreased the expression of G0/G1-specific regulatory proteins, including proliferating cell nuclear antigen (PCNA), CDK2, cyclin D1, cyclin E and CDK4 in PDGF-ββ-treated VSMCs. Moreover, pretreatment with atorvastatin calcium inhibited the PDGF-ββ-treated phosphorylation of PDGFRβ and Akt, whereas atorvastatin calcium did not affect the phosphorylation of PLC-γ1 or (ERK) 1/2. Conclusion: Our data suggested that atorvastatin calcium inhibited abnormal proliferation and migration of VSMCs through G0/G1 cell cycle arrest and suppression of the PDGFRβ-Akt signaling cascade.
Databáze: OpenAIRE